GSK says its RSV vaccine shows potential for adults in their 50's

Primary tabs

GSK says its RSV vaccine shows potential for adults in their 50's

...The British drugmaker's shot, called Arexvy, met the primary goal in the Phase-III trial of eliciting an immune response in adults of the reported age group who are at an increased risk of catching the virus due to certain underlying medical conditions, the company said on Wednesday.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
Workflow history
Revision ID Field name Date Old state New state name By Commentaire Operations
No state No state
howdy folks
Page loaded in 0.467 seconds.